Lama Sing:  These are in part at least the qualities that were chosen for the incarnation, or perhaps in another manner, accepted.  These are qualities which are preponderant in the incarnation and are seen, known, even explored prior to the entry.  The recognition of these then, in the journey itself, is a valuable adjunct to reaching that point of claiming.  It is not (see, underscore this), it is not the disassembly of self and the analytical process of probing, exploring, balancing, measuring each part of self, but seeing these parts as step-stones no matter how so grievous one might adjudge a decision or a portion of one’s life.  These are the very, shall we call them, opportunities that are being sought to be answered.  If one cannot move beyond the parts of the whole, how can they ever become the whole?

In 2005 Al was diagnosed with stage 4 COPD, with a 30% lung capacity and an approximate 4-year life expectancy. Lama Sing told Al that, in spite of the diagnosis of emphysema, this was not the case, and gave Al a regimen of suggestions. Since that time, Al has done remarkably well. As with many who have utmost faith, he has applied all he’s known to do to the best of his ability, yet while he has defied all odds, he has not cured himself of this disease. It has been given many times by Lama Sing that dis-ease of any sort is always a choice. What is often not understood is that this choice is not infrequently made prior to incarnation for any variety of reasons. If and when those reasons have been fulfilled or even set aside, that one can choose to be released from the opportunity of the burden chosen.

It was not until several years into it that Al was tested and discovered to be “Alpha-1”. Remarkably, no pulmonologist ever suggested the treatment, which is a replacement for the deficiency, and neither did Lama Sing volunteer it since that goes against Universal Law. Until May 2017, Al and Susan were unaware that a treatment for Alpha-1  even existed.

Given all this, the conclusion Al has come to is that the purpose for this remains and will be revealed in time. He continues to live in peace and joy, dedicated to God and to the “Return,” his goal to remain until that Time. Since this is now “the hour” for the Return, according to a reading given May 28, we are joyfully expectant that Al will reach his goal.

We thank you all for your ongoing prayers. Al is currently under the wonderful in-home care of Hope Hospice.

Information on Alpha-1

What is Alpha-1?
Alpha-1 Antitrypsin Deficiency (Alpha-1) is a genetic (inherited) condition – it is passed from parents to their children through their genes. Alpha-1 may result in serious lung disease in adults and/or liver disease at any age. 

Lung Disease
Alpha-1 Antitrypsin Deficiency (Alpha-1) is a genetic condition passed from parents to their children through their genes. Because Alpha-1 is genetic, Alpha-1 lung disease is commonly called “genetic COPD.”

The specific treatment of Alpha-1-related lung disease is augmentation therapy, also called replacement therapy, the use of alpha-1 antitrypsin protein (AAT) from the blood plasma of healthy donors. The therapy is administered by a weekly intravenous infusion and, for now, is considered lifelong.

Augmentation therapy has been shown to reduce the rate of decline of lung function, and improve survival. It cannot restore lost lung function and is not considered a cure. However, this therapy is currently the standard of care for Alphas with COPD.

Alpha-1 Foundation Logo